Total Visits

Views
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group Study134

Total Visits Per Month

March 2024April 2024May 2024June 2024July 2024August 2024September 2024
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group Study4116195

Top country views

Views
United States57
Poland52
China13
Japan3
Australia2
France2
Ireland2
Argentina1
Belgium1
Russia1

Top cities views

Views
Warsaw52
Beijing8
Boardman8
San Ramon8
Ashburn7
San Mateo7
Louisville6
Ann Arbor5
Des Moines4
Chaoyang3